INDV (INDV) Stock Price & Analysis
INDV (INDV) rose 0.32% to USD 34.94 as of September 8, 2026 at 05:47 UTC, according to Nexqual real-time market data.
INDV last closed at USD 34.94; the session ranged USD 34.55–35.31 on volume of 1,019,385 shares. Market capitalization is —, with a 52-week range of USD 22.22–42.81 (NMS). Source: Nexqual, September 8, 2026 at 05:47 UTC.
Key Statistics (as of September 8, 2026 at 05:47 UTC)
| Price | USD 34.94 |
|---|---|
| Change | ▲ 0.32% (up) |
| Previous Close | USD 34.94 |
| Open | USD 34.94 |
| Day Range | USD 34.55 – 35.31 |
| 52-Week Range | USD 22.22 – 42.81 |
| Volume | 1,019,385 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (INDV)
Nexqual's technical model rates INDV "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:47 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 30.86 (neutral) |
| vs SMA50 | Below (USD 38.8) |
| MACD | -1.18 (negative) |
From INDV's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BTSG | BrightSpring Health Services, I | USD 60.73 | ▲ 0.8% |
| MLYS | Mineralys Therapeutics, Inc. | USD 28.21 | ▼ 2.86% |
| TVTX | Travere Therapeutics, Inc. | USD 65.28 | ▼ 2.9% |
| ELVN | Enliven Therapeutics, Inc. | USD 59.32 | ▲ 0.53% |
| SYRE | Spyre Therapeutics, Inc. | USD 88.98 | ▲ 2.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:47 UTC. This page is informational and not investment advice.